Consequences of Metabolic Disruption in Alzheimer's Disease Pathology
Open Access
- 1 July 2019
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 16 (3) , 600-610
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (RO1AG055059)
This publication has 147 references indexed in Scilit:
- Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetesNeurobiology of Learning and Memory, 2011
- Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 DiabetesArchives of Neurology, 2011
- Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain AgingJAMA, 2009
- Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in MiceCell, 2009
- Seizures in Alzheimer DiseaseArchives of Neurology, 2009
- Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer TypeArchives of Neurology, 2009
- Epilepsy and Cognitive Impairments in Alzheimer DiseaseArchives of Neurology, 2009
- Aβ amyloid and glucose metabolism in three variants of primary progressive aphasiaAnnals of Neurology, 2008
- The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian ControlCell, 2008
- SIRT1 Regulates Circadian Clock Gene Expression through PER2 DeacetylationCell, 2008